2026. Thermosensitive In Situ Nasal Gel Incorporating Chitosan Nanoparticles of Zolmitriptan for Migraine Management: Formulation Strategies, Optimization, and Characterization— A Review. International Journal of Pharmaceutical Drug Design. 3, 1 (May 2026), 196–204. DOI:https://doi.org/10.62896/ijpdd.3.1.24.